Literature DB >> 2082008

Melatonin effects on the cytoskeletal organization of MDCK and neuroblastoma N1E-115 cells.

G Benítez-King1, L Huerto-Delgadillo, F Antón-Tay.   

Abstract

Despite the fact that many physiological and pharmacological actions of melatonin (MEL) have been described, its mechanism of action at the subcellular level remains unclear. It has been suggested that MEL has effects on cellular processes that involve microfilaments and microtubules. In the present study MEL effects on the cytoskeleton were evaluated in MDCK and N1E-115 cells in which the microfilaments have been shown to participate in cell morphology and dome formation (MDCK) and the microtubules in neurite outgrowths. After one day of culture with 10(-11)-10(-7) M MEL MDCK cells showed an increase in the number of elongated cells. After four days with the hormone, an increase in the incidence of MDCK cells contacting neighboring cells through long cytoplasmic elongations was observed. Actin antibody stain showed the appearance of thicker fluorescent fibres beneath the cell membrane and over the nucleus in the MEL treated cells. An increase in dome formation in confluent cells was also observed. In N1E-115 cells MEL (10(-13)-10(-5) M) induced an increase in cell with neurite processes. Neurite outgrowth is clearly seen at 24 h after plating. MEL-treated cells grow in clusters with neurites forming intricate networks. Antitubulin antibody stain showed long fluorescent neurites in the N1E-115 MEL-treated cells. A decrease in N1E-115 neurite formation was observed with either serotonin or 6-hydroxymelatonin (6OH-MEL). However, the number of MDCK cells with cytoplasmic elongations was decreased only after 6OH-MEL. We conclude that MEL action at the cellular level involves a modification of the cytoskeletal organization.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2082008     DOI: 10.1111/j.1600-079x.1990.tb00709.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  9 in total

Review 1.  Melatonin: an inhibitor of breast cancer.

Authors:  Steven M Hill; Victoria P Belancio; Robert T Dauchy; Shulin Xiang; Samantha Brimer; Lulu Mao; Adam Hauch; Peter W Lundberg; Whitney Summers; Lin Yuan; Tripp Frasch; David E Blask
Journal:  Endocr Relat Cancer       Date:  2015-04-15       Impact factor: 5.678

2.  In vitro stimulation of protein kinase C by melatonin.

Authors:  F Antón-Tay; G Ramírez; I Martínez; G Benítez-King
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

3.  Comparison of melatonin with growth factors in promoting precursor cells proliferation in adult mouse subventricular zone.

Authors:  Areechun Sotthibundhu; Kasima Ekthuwapranee; Piyarat Govitrapong
Journal:  EXCLI J       Date:  2016-12-21       Impact factor: 4.068

4.  Melatonin: neuritogenesis and neuroprotective effects in crustacean x-organ cells.

Authors:  Gregory A Cary; Anne S Cuttler; Kirsten A Duda; Escar T Kusema; Jennifer A Myers; Andrea R Tilden
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2011-12-16       Impact factor: 2.320

5.  Ocular hypotensive effects of melatonin receptor agonists in the rabbit: further evidence for an MT3 receptor.

Authors:  Jesus Pintor; Teresa Peláez; Charles H V Hoyle; Assumpta Peral
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

6.  Effect of melatonin on beta-tubulin and MAP2 expression in NIE-115 cells.

Authors:  J Meléndez; V Maldonado; A Ortega
Journal:  Neurochem Res       Date:  1996-06       Impact factor: 3.996

Review 7.  Calmodulin mediates melatonin cytoskeletal effects.

Authors:  G Benítez-King; F Antón-Tay
Journal:  Experientia       Date:  1993-08-15

8.  Influence of Melatonin on the Proliferative and Apoptotic Responses of the Prostate under Normal and Hyperglycemic Conditions.

Authors:  Marina G Gobbo; Nishtman Dizeyi; Per-Anders Abrahamsson; Per-Anders Bertilsson; Viviane Sanches Masitéli; Eloisa Zanin Pytlowanciv; Sebastião R Taboga; Rejane M Góes
Journal:  J Diabetes Res       Date:  2015-07-30       Impact factor: 4.011

9.  Melatonin-Induced Cytoskeleton Reorganization Leads to Inhibition of Melanoma Cancer Cell Proliferation.

Authors:  Alejandro Alvarez-Artime; Rafael Cernuda-Cernuda; Vanesa Cepas; Pedro Gonzalez-Menendez; Sheila Fernadez-Vega; Isabel Quiros-Gonzalez; Rosa M Sainz; Juan C Mayo
Journal:  Int J Mol Sci       Date:  2020-01-15       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.